EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulation of AMPK by esomeprazole and canagliflozin mitigates methotrexate-induced hepatotoxicity: involvement of MAPK/JNK/ERK, JAK1/STAT3, and PI3K/Akt signaling pathways

Ahmed M El-Dessouki, Mohamed E Kaml, Mohammed F El-Yamany

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-08 · 398 (8) · 10901-10919

DOI: 10.1007/s00210-025-03908-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 07.03.2025. Verfasst von Ahmed M El-Dessouki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology and Toxicology Department, Faculty of Pharmacy, Ahram Canadian University (ACU), 6th of October City, Giza, 12566, Egypt. ahmed.desoky@a…. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Methotrexate, Canagliflozin, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ahram Canadian University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research investigated the hepatoprotective effects of esomeprazole (ESOM) and canagliflozin (CANA) against methotrexate-induced liver toxicity, focusing on AMPK modulation and its regulation of MAPK/JNK/ERK, JAK1/STAT3, and PI3K/Akt pathways. Fifty male Wistar rats were divided into five groups: control, MTX, and three pretreatment groups receiving ESOM (30 mg/kg), CANA (30 mg/kg), or their combination. ESOM and CANA were administered for 8 days before and 1 day after a single MTX injection (20 mg/kg, intraperitoneally) on day 9 to induce hepatotoxicity. Liver injury, oxidative stress, inflammation, and apoptosis were assessed using biochemical, histopathological, immunohistochemical, qRT-PCR, and western blot analyses. Data were analyzed by one-way analysis of variance (ANOVA) and Tukey’s post hoc test, with significance at p < 0.05. Results were presented as mean ± standard error (SE). Rats that received MTX showed significant liver damage, marked by elevated ALT, AST, MDA, MPO, iNOS, TNF-α, IL-6, and IL-1β levels ( p < 0.01) and decreased antioxidant enzymes (HO-1, Nrf2, and GSH). Immunohistochemistry revealed increased NF-kB p65 and caspase-9 expression ( p < 0.01), correlating with histopathological changes. Pretreatment with ESOM and CANA reduced liver enzyme levels, improved histology, restored antioxidant balance, and inhibited inflammatory pathways via p38MAPK/NF-kB p65 and JAK1/STAT3 ( p < 0.01). Moreover, ESOM and CANA preserved PI3K/Akt activity and prevented caspase-dependent apoptosis ( p < 0.01). Additionally, the combination treatment showed synergistic hepatoprotective effects, demonstrated by significant improvements in all measured parameters. These findings suggested that ESOM and CANA had significant potential as therapeutic agents for alleviating MTX-induced hepatotoxicity and warranted further investigation in future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryMethotrexateCanagliflozinAMP-Activated Protein KinasesAnimalsMaleRats, WistarSTAT3 Transcription FactorJanus Kinase 1Signal TransductionProto-Oncogene Proteins c-aktRatsLiverOxidative StressApoptosisPhosphatidylinositol 3-KinasesMAP Kinase Signaling System

Stichwörter der Autor:innen

AMPKCanagliflozinEsomeprazoleHepatoxicityMAPKMethotrexate

Substanzen

STAT3 Transcription FactorMethotrexateJanus Kinase 1Stat3 protein, ratJak1 protein, ratCanagliflozinProto-Oncogene Proteins c-aktAMP-Activated Protein KinasesPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Pharmacology and Toxicology Department, Faculty of Pharmacy, Ahram Canadian University (ACU), 6th of October City, Giza, 12566, Egypt. ahmed.desoky@acu.edu.eg.
  • Pharmacology and Toxicology Department, Faculty of Pharmacy, Ahram Canadian University (ACU), 6th of October City, Giza, 12566, Egypt.
  • Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Giza, 11562, Egypt.

Förderung

  • Ahram Canadian University

Zitieren

APA

El-Dessouki, A. M., Kaml, M. E., & El-Yamany, M. F. (2025). Modulation of AMPK by esomeprazole and canagliflozin mitigates methotrexate-induced hepatotoxicity: involvement of MAPK/JNK/ERK, JAK1/STAT3, and PI3K/Akt signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(8), 10901-10919. https://doi.org/10.1007/s00210-025-03908-3

Vancouver

El-Dessouki AM, Kaml ME, El-Yamany MF. Modulation of AMPK by esomeprazole and canagliflozin mitigates methotrexate-induced hepatotoxicity: involvement of MAPK/JNK/ERK, JAK1/STAT3, and PI3K/Akt signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(8):10901-10919. doi:10.1007/s00210-025-03908-3

BibTeX
@article{ElDessouki2025,
  author = {El-Dessouki, Ahmed M and Kaml, Mohamed E and El-Yamany, Mohammed F},
  title = {Modulation of AMPK by esomeprazole and canagliflozin mitigates methotrexate-induced hepatotoxicity: involvement of MAPK/JNK/ERK, JAK1/STAT3, and PI3K/Akt signaling pathways},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  volume = {398},
  number = {8},
  pages = {10901--10919},
  doi = {10.1007/s00210-025-03908-3}
}
Kostenlos starten →